ANURAG GUPTA

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism ROCKVILLE, MD NPI 1104828441

General Payments — all program years on this page

$405.76

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $271.83 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $271.8314

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $53.603
Lilly USA, LLC $48.722
Amgen Inc. $46.812
ABBVIE INC. $37.762
PFIZER INC. $21.401
Amneal Pharmaceuticals LLC $17.221
Novo Nordisk AS $16.951
Radius Health, Inc. $14.891
Corium, Inc. $14.481

By program year

Program yearAmountRecords
2018 $76.246
2019 $40.922
2020 $16.771
2024 $271.8314

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089935986 Radius Health, Inc. $14.89 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096579085 Novo Nordisk Inc $16.95 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100114214 Corium, LLC $14.48 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103851886 ABBVIE INC. $14.42 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103851888 ABBVIE INC. $23.34 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111591142 Amgen Inc. $23.98 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111591144 Amgen Inc. $22.83 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874651 Boehringer Ingelheim Pharmaceuticals, Inc. $16.09 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874653 Boehringer Ingelheim Pharmaceuticals, Inc. $16.11 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117874655 Boehringer Ingelheim Pharmaceuticals, Inc. $21.40 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131732997 PFIZER INC. $21.40 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136045309 Lilly USA, LLC $21.28 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136061362 Lilly USA, LLC $27.44 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139187816 Amneal Pharmaceuticals LLC $17.22 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.